Kurt Reichen

mFoundry, Inc. provides mobile financial services. Its mobile banking and mobile payments solutions are based upon a market-proven platform that was designed to help their clients create deeper, more valuable relationships with their customers. The company was founded by Rodney Aiglstorfer in 2004 and is headquartered in San Francisco, CA.

Melodeo, Inc. offers mobile podcasting solutions. The firm delivers music and other media via mobile phones and web. It also provides wireless customers with music, comedy, news, sports, and entertainment programs, including radio shows. The company was founded by Bill Valenti, Donald Davidge and Loreen Milbrath in 2003 and is headquartered in Seattle, WA.

Ingenuity Systems, Inc. provides intuitive web-based applications for quickly analyzing and accurately interpreting the biological meaning of genomics data. The company was founded in 1998 and is headquartered in Redwood City, CA.

Yeelion Online Network Technology (Beijing) Co. Ltd. is engaged in the provision of online digital media services. Its music software, Koowo, is a media player plug-in to auto search for matching lyrics, images and music videos. The company was founded in August 2005 and is headquartered in Beijing, China.

Sensor Innovations, Inc. develops and commercializes a novel, proprietary and versatile sensing technology platform. It is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, continuously self-calibrating sensor without drift is advantageous. The company was founded by Carolyn R. Kahn in 2007 and is headquartered in Burlingame, CA.

ArmaGen, Inc. engages in operation of a clinical stage biotechnology company focused on developing revolutionary therapies for severe neurological disorders. Its products include AGT-110-Brain-penetrating biologic tumor necrosis factor inhibitor (TNFI) for Alzheimer's disease, AGT-115-Brain-penetrating erythropoietin (EPO) for stroke, AGT-160-Brain penetrating anti-amyloid antibody (AAA) for Alzheimer's disease and AGT-181-Brain-penetrating iduronidase (IDUA) for Mucopolysaccharidosis (MPS) Type I (Hurler's syndrome). The company was founded by William M. Pardridge and Ruben J. Boado in 2003 and is headquartered in San Diego, CA.

Part of Bank of America Corp., Merrill Lynch Capital Partners, Inc. is a security broker and dealer. The company is based in New York, NY. The company was founded by Jim J. Burke.

Maritime Telecommunications Network, Inc. provides vital and satellite communication services. It offers connectivity, digital media, system integration, and equipment. The firm serves commercial shipping, cruise and ferry, energy, enterprise, government, mobile network operators, and yacht. The company was founded in 1981 and is headquartered in Miramar, FL.

Ignition Venture Partners (Ignition Venture) is a venture capital firm subsidiary of Ignition Partners Group founded in 2000 by Cameron Myhrvold, Jonathan D Roberts, Jon Anderson, and John Ludwig. The firm is headquartered in Bellevue, Washington.

Liberty Dialysis LLC develops and operates dialysis clinics. It offers chronic kidney disease outreach and home dialysis programs for patients. The firm also partners with local nephrologists and hospitals in developing, owning, and operating these centers. The company was founded by Mark Caputo and Bob Santelli in 2002 and is headquartered in Mercer Island, WA.

OrSense Ltd. develops and markets non-invasive monitoring systems for measurement of hemoglobin. Its products include NBM 200 is a non-invasive finger blood analytics monitor measures and displays arterial blood hemoglobin and pulse rate values; Glasswing offers a unique, breakthrough non-invasive solution for hemoglobin measurements; and SpectOLight Sensor non-invasive optical measurement platform includes a ring-shaped sensor probe fitted around the subject's finger. The company was founded in Shimon Eckhouse, Ilya Fine and Alex Sternberg in 1996 and is headquartered in Petah Tikva, Israel.

The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC.

Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ.

Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada.

Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China.

FLG Partners LLC is a CFO solutions, CEO, and board advisory services provider based in Silicon Valley. The private company is based in Palo Alto, CA, and has subsidiaries in the United States. The company offers financial and operational leadership to a wide range of companies, from newly funded startups to Fortune 100 companies, across various sectors, including technology, life sciences, and consumer products. The firm's partners engage clients in interim or long-term assignments in leadership roles that typically are consulting engagements. FLG Partners has helped raise over $6 billion in growth financing, IPO, and M&A transactions for the firm's clients since January 2021. The company was founded by Douglas J. Lehrmann, Jeffrey S. Kuhn, Kyle W. Smith.

Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017.

Firecyte Therapeutics, Inc. is an emerging biotechnology company based in Cambridge, MA that is focused on developing novel treatment strategies for progressive neurodegenerative diseases of the eye. The company's research is centered around the role of microglia and neuroinflammation in these diseases. The team is led by Jonathan Levenson, the Chief Scientific Officer, who has over 16 years of experience in neuropsychiatry, neurodegeneration, and neuroinflammation. The company was founded by Dong Feng Chen and William E. Yelle, who has been the CEO since incorporation.